Bringing regenerative medicines to the clinic: the future for regulation and reimbursement July 16, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.futuremedicine.com/doi/10.2217/rme.15.51 Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related